CLINICAL TRIALS PROFILE FOR MONTELUKAST SODIUM
✉ Email this page to a colleague
All Clinical Trials for MONTELUKAST SODIUM
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000577 ↗ | Asthma Clinical Research Network (ACRN) | Withdrawn | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1993-09-01 | This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma. |
| NCT00000577 ↗ | Asthma Clinical Research Network (ACRN) | Withdrawn | Milton S. Hershey Medical Center | Phase 3 | 1993-09-01 | This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma. |
| NCT00076973 ↗ | An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2003-08-01 | The purpose of this study is to look at whether an investigational drug can treat the breathing symptoms of RSV bronchiolitis in children 3 to 24 months of age. |
| NCT00092105 ↗ | Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2002-04-01 | The purpose of this study is to determine the protective effect of an approved medication on asthma and allergic rhinitis (inflammation of the mucous membrane of the nose) upon exposure to cats. |
| NCT00092989 ↗ | Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2004-07-01 | The purpose of this study is to evaluate improved results of treatment for patients entering an emergency department with asthma attacks when given an investigational IV administration of an approved drug (MK-0476, montelukast sodium) in addition to approved standard treatment. |
| NCT00117338 ↗ | A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2005-07-01 | This study will attempt to find out if the addition of an intravenous form of a drug that is already used for treating asthma in children will help resolve asthma attacks faster than using the current standard care alone. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MONTELUKAST SODIUM
Condition Name
Clinical Trial Locations for MONTELUKAST SODIUM
Trials by Country
Clinical Trial Progress for MONTELUKAST SODIUM
Clinical Trial Phase
Clinical Trial Sponsors for MONTELUKAST SODIUM
Sponsor Name
